Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes (Q39744237)

14 September 2017

Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes (English)

1 reference

14 September 2017

1 reference

Michael J Lace

1

1 reference

14 September 2017

James R Anson

series ordinal

2

1 reference

14 September 2017

Thomas H Haugen

series ordinal

3

1 reference

14 September 2017

Lubomir P Turek

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

2 February 2010

1 reference

14 September 2017

1 reference

14 September 2017

399

1 reference

14 September 2017

2

1 reference

14 September 2017

270-279

1 reference

The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

A functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

IRF regulation of HIV-1 long terminal repeat activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Signal Transduction and the Control of Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Toll-like receptor signaling and IRF transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

An enhancer-like element in the adenovirus E2 promoter contains sequences essential for uninduced and E1A-induced transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Evolving immunosuppressive microenvironment during human cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Control of interferon signaling in human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Regulation of STAT-dependent pathways by growth factors and cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Transcription activation by the adenovirus E1a protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Oncogenic activities of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

IRF-1 as a negative regulator of cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Immunobiology of HPV and HPV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

The IRF family transcription factors in immunity and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

IRF family of transcription factors as regulators of host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Distinct classes of transcriptional activating domains function by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Roles of the JAK-STAT system in signal transduction via cytokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

inferred from DOI database lookup

7 January 2021

based on heuristic

DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.12.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2009.12.025

1 reference

14 September 2017

1 reference